Tadokoro T, Ikeda K, Sudo K, Mizuno A, Ohbayashi T, Morita H, Unno T, Hayashi N, Noguchi K
Rinsho Kyobu Geka. 1989 Oct;9(5):490-3.
We have implanted cardiac pacemaker (PM) in 3 early neonates ranging from 5 hours old to 7 days old of age with congenital complete or incomplete AV block. They were in advanced stage of rapidly developed cardiac failure with resistance to drug therapy and with ventricular tachycardia or fibrillation. Cardiac failure was improved immediately in the 3 cases after the operation and the effectiveness by the pacing was recognized for a long term observation (4 months to 2 years). There appeared PM implantation in-14 neonates, including our cases, in Japanese literatures. In review of the 14 neonates, we discussed the autoimmune disease, indication of the pacing, implantation site of the PM generator and prognosis. An immediate PM implantation after birth in neonate with cardiac failure complicated by congenital AV block is treatment of choice. The generator as well as the electrode design for neonates are still yet to be developed.
我们为3例年龄在5小时至7天的先天性完全性或不完全性房室传导阻滞的早期新生儿植入了心脏起搏器(PM)。他们处于快速进展的心力衰竭晚期,对药物治疗耐药,并伴有室性心动过速或颤动。术后这3例患儿的心力衰竭立即得到改善,且通过起搏的有效性得到了长期观察(4个月至2年)的认可。在日本文献中,包括我们的病例在内,有14例新生儿接受了PM植入。回顾这14例新生儿,我们讨论了自身免疫性疾病、起搏指征、PM发生器的植入部位和预后。对于伴有先天性房室传导阻滞的心力衰竭新生儿,出生后立即植入PM是首选治疗方法。针对新生儿的发生器以及电极设计仍有待开发。